Although the use of power morcellators during non-invasive gynecological procedures has declined significantly following FDA warnings issued in 2014 associating the device with the spread of uterine cancer, the cancer risk did not go down, according to a study published recently in the Journal of the American Medical Association.
Women continue to file lawsuits against the manufacturers of the power morcellators based on the fact that they were put at increased risk of uterine cancer during morcellation.
According to the study, among women undergoing minimally invasive hysterectomy, the use of power morcellators declined from a peak of almost 14 percent in late 2013, before the FDA warning, to less than three percent by early 2015.
However, the rate of uterine cancer in women treated with morcellators actually increased from 0.28 percent before the FDA advisory to 0.53 percent afterward.
Researchers commented that the results showed that even with all the increased guidance and scrutiny involving the devices, some women who underwent morcellation still developed cancer, reinforcing the notion that there is no patient for which morcellation does not pose a cancer risk.
A 2014 editorial published in the Lancet Oncology noted that the cancer risk connected with power morcellators has actually been known for at least 20 years.
The findings of the study rekindled a discussion that has been ongoing since 2013, when the Society of Gynecologic Oncology published a position statement cautioning practitioners regarding the use of morcellation to treat uterine fibroids, citing several reports that the procedure had released cells from undiagnosed leiomyosarcoma that progressed into advanced uterine cancer.
According to the FDA, approximately one in 350 women undergoing hysterectomy is found to have an unsuspected uterine sarcoma, a type of uterine cancer that includes leiomyosarcoma that is spread throughout the pelvis and abdomen during the morcellation process.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
512 cases (2,048 trays) of Gordon Food Service (GFS) Sienna Bakery® Chocolate Decadent Brownies (GFS#226240) and Sienna Bakery® Chocolate Peanut Butter Brownies have been recalled by Dianne’s Fine Desserts due to a mislabeling and undeclared peanut, according to the FDA. Consumers who are allergic or
According to the FDA, Baxter Healthcare Corporation’s September 21, 2023 recall of its Novum IQ Syringe Pump is now identified as Class I, the most serious type, because use of the device has been found to put users at risk of serious injuries or death.
Publix Supermarkets, Inc., of Lakeland, Florida, has voluntarily recalled certain batches of private-label Egg Custard Pie sold between October 20, 2023 and November 16, 2023 because they may contain coconut, an allergen not listed on the product’s ingredient statement. Officials say the affected packages, which